ADVISORY/ CIBC World Markets First Annual Bio-Technology Conference Featuring Presentations From Industry Leaders.Business Editors and Biotechnology Writers ADVISORY...for Wednesday-Thursday (May 2-3) --(BUSINESS WIRE) CIBC World Markets CIBC World Markets is the investment banking division of the Canadian Imperial Bank of Commerce. It helps governments, large companies, and other large institutions obtain capital and credit and is a primary dealer in U.S. Treasury securities.
EVENT: CIBC WORLD MARKETS FIRST ANNUAL BIO-TECHNOLOGY CONFERENCE
FEATURING PRESENTATIONS FROM INDUSTRY LEADERS
Senior Executives of Amgen, Celera Genomics, Human Genome
Sciences, Millennium Pharmaceuticals, Myriad Genetics,
Seattle Genetics Among Featured Speakers
DATE: May 2 and 3, 2001
TIME: 7:30 A.M. - 5:00 P.M.
LOCATION: Millennium Broadway Hotel
145 West 44th St.
New York, New York
212-768-4400
MEDIA
CREDENTIALS: DUE TO LIMITED SPACE, WORKING MEMBERS OF THE MEDIA
INTERESTED IN COVERING THE CONFERENCE MUST BE
CREDENTIALED.
The latest developments in antibodies, genomics, proteomics, molecular diversity, mass spectrometry mass spectrometry or mass spectroscopy Analytic technique by which chemical substances are identified by sorting gaseous ions by mass using electric and magnetic fields. , drug discovery hardware and bioinformatics Using computers in biological research to analyze or predict the composition of molecules (nucleic acids, proteins, etc.) and model biologic systems. Bioinformatics is most prominent in the Human Genome Project, which has recorded the three billion chemical base pairs that make up the will be among the featured topics of the 72 unique presentations to be given during the CIBC World Markets First Annual Bio-Technology Conference. The conference will be held May 2 - 3, 2001 at the Millennium Broadway Hotel in New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of . Senior executives from more than 70 leading bio-tech companies from across the country including, Amgen, Celera Genomics, Caliper caliper Instrument that consists of two adjustable legs or jaws for measuring the dimensions of material parts. Spring calipers have an adjusting screw and nut; firm-joint calipers use friction at the joint to hold the legs unmoving. Technologies, Humane humane pertaining to the avoidance of infliction of pain, discomfort and harassment; used especially with regard to animals. humane considerations Genome genome: see genetics. genome all the genetic content contained within an organism. An organism's genome is made up of molecules of deoxyribonucleic acid (DNA) that form long strands that are tightly wound into chromosomes, which are found in the Sciences, MDS MDS, n See temporomandibular pain-dysfunction syndrome. MDS 1 Maternal deprivation syndrome, see there 2 Myelodysplastic syndrome, see there Proteomics, and ZymoGenetics will provide up-to-date information focusing on the status and key aspects of their company's technology and products. CIBC World Markets, the investment-banking subsidiary of the Canadian Imperial Bank of Commerce The Canadian Imperial Bank of Commerce TSX: CM NYSE: CM, better known to most customers as CIBC, is one of Canada's major banks. CIBC is classified as a Domestic Chartered Bank (Schedule I). offers a full range of integrated credit and capital markets products, securities, and brokerage and asset management services to corporate, government, institutional and individual clients.
PARTIAL LISTING OF SPEAKERS
Wednesday, May 2
Morning Sessions
Amgen: William J. Boyle, Ph.D., Director of Research
Celera Genomics: Dr. Scott Patterson, Senior Director, Proteomics
Seattle Genetics: Clay Siegall, Ph.D., Chief Executive Officer
Luncheon Speaker
Memorial Sloan-Kettering Cancer Center: David Golde, M.D.,
Physician-in-Chief
Topic: Cancer Care in the 21st Century
Afternoon Sessions
Celera Genomics: Jack W. Singer, M.D., Executive Vice President &
Research Chairman
Genetech: Paul J. Godowski, Ph.D., Senior Director, Research:
Molecular Biology
Myriad Genetics: Sudhir Sahasrabudhe, Ph.D., Executive Vice President
of Research
Thursday, May 3
Morning Sessions
Human Genome Sciences: Craig A. Rosen, Executive Vice President,
Research & Development
Caliper Technologies: Daniel L. Kisner, President &
Chief Executive Officer
Cephalon: Jeffrey L. Vaught, Ph.D., Senior Vice President &
President, Research & Development
Luncheon Speaker
International Intellectual Property Institute (IIPI): Bruce A. Lehman,
President
Topic: Intellectual Property Issues in Healthcare
Afternoon Sessions
Applied Biosystems: Tony White, Chairman, President &
Chief Executive Officer
Gene Logic: Mark D. Gessler, President & Chief Executive Officer
Variagenics: Rick Shea, Chief Financial Officer
|
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion